These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10314269)

  • 21. Quality assurance for the JCAHO standards.
    Chase PA
    Am J Hosp Pharm; 1991 Jul; 48(7):1550-2. PubMed ID: 1882891
    [No Abstract]   [Full Text] [Related]  

  • 22. Joint Commission charts new course for quality assurance.
    O'Leary D
    Am J Hosp Pharm; 1986 Oct; 43(10):2403. PubMed ID: 3466535
    [No Abstract]   [Full Text] [Related]  

  • 23. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplistic approach to establishing drug usage/quality assurance programs.
    Adachi W
    Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-usage evaluation: a system for the prospective evaluation of antibiotic utilization in minimum inhibitory concentration documented infections.
    Sharp WT; Driver P; Bartlome P
    Top Hosp Pharm Manage; 1991 Jul; 11(2):59-69. PubMed ID: 10128636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 27. Time limit on multidose vials after initial entry.
    Moi S; Thornton JP
    Hosp Pharm; 1991 Sep; 26(9):805, 809. PubMed ID: 10114012
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug newsletters and quality assurance of drug usage.
    Plumridge RJ; Greenhill GT; Blackbourn J
    Hosp Pharm; 1988 Aug; 23(8):718, 720-4, 729. PubMed ID: 10288921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new survey process and input into standards development.
    Rich DS
    Hosp Pharm; 1994 Mar; 29(3):289-90. PubMed ID: 10132700
    [No Abstract]   [Full Text] [Related]  

  • 30. Quality improvement indicators for hospital/home care pharmacy.
    Rich DS
    Hosp Pharm; 1993 Oct; 28(10):992, 994-5. PubMed ID: 10129143
    [No Abstract]   [Full Text] [Related]  

  • 31. Meeting JCAHO drug usage evaluation requirements in a small hospital.
    Moline KA
    Hosp Pharm; 1990 May; 25(5):486-8, 492. PubMed ID: 10104827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of pharmacotherapy: the role of pharmacy as quality assurance.
    Barnett MD; Fary D; Carroll NV; Miederhoff PA
    Top Hosp Pharm Manage; 1990 Nov; 10(3):47-56. PubMed ID: 10128578
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of a quality control methodology for a pharmacokinetic service.
    Whipple JK; Bubrick J; Ausman RK; Quebbeman EJ; Franson TR
    Top Hosp Pharm Manage; 1988 Feb; 7(4):55-61. PubMed ID: 10318012
    [No Abstract]   [Full Text] [Related]  

  • 34. Using databases in pharmacies.
    MacKinnon G; Wuller W
    Healthc Inform; 1993 Jun; 10(6):34-6, 38, 40. PubMed ID: 10126967
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse drug reaction reporting--proposal to implement a revised system.
    Linkewich JA
    Hosp Pharm; 1989 Feb; 24(2):122-4. PubMed ID: 10292192
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacy strategies for antibiotic review.
    Leist ER; Ford DC
    Top Hosp Pharm Manage; 1981 Nov; 1(3):53-64. PubMed ID: 10313954
    [No Abstract]   [Full Text] [Related]  

  • 37. A bibliography to assist in meeting JCAHO QA and drug usage evaluation standards.
    Thornton JP
    Hosp Pharm; 1989 Mar; 24(3):231, 234. PubMed ID: 10303340
    [No Abstract]   [Full Text] [Related]  

  • 38. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective dosage adjustment program in a geriatric population.
    Guharoy SR
    Top Hosp Pharm Manage; 1994 Apr; 14(1):67-72. PubMed ID: 10171827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How accelerated regulation will affect point-of-care testing.
    Krienitz D; Little J
    MLO Med Lab Obs; 1991; 23(9S Spec No):47-51. PubMed ID: 10170836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.